Dear Health Care Professional,

BMS has made the decision to change the way in which we engage with you.

For Medical information related requests please contact medical.information@bms.com and for general enquiries please contact communicationuki@bms.com.

Adverse events should be reported. Reporting forms and information can be found at: UKhttps://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App Store; Ireland – via HPRA Pharmacovigilance at www.hpra.ie. Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK); 1 800 749 749 (Ireland).

For any enquiries regarding risk management (for example relating to the Pregnancy Prevention Programme) please contact the BMS Patient Safety Team. For contact details refer to the BMS PRODUCT Additional Risk Minimisation Materials available on the electronic medicines compendium (UK) or medicines.ie (Ireland).

We remain committed to Haematology as we prepare for the future.

For more BMS information please click here to visit our website.

Yours sincerely,
Bristol Myers Squibb.

Dear Health Care Professional,

BMS has made the decision to change the way in which we engage with you.

For Medical information related requests please contact medical.information@bms.com and for general enquiries please contact communicationuki@bms.com.

Adverse events should be reported. Reporting forms and information can be found at: UKhttps://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App Store; Ireland – via HPRA Pharmacovigilance at www.hpra.ie. Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK); 1 800 749 749 (Ireland).

For any enquiries regarding risk management (for example relating to the Pregnancy Prevention Programme) please contact the BMS Patient Safety Team. For contact details refer to the BMS PRODUCT Additional Risk Minimisation Materials available on the electronic medicines compendium (UK) or medicines.ie (Ireland).

We remain committed to Haematology as we prepare for the future.

For more BMS information please click here to visit our website.

Yours sincerely,
Bristol Myers Squibb.

Adverse events should be reported. Reporting forms and information can be found at: UKwww.mhra.gov/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App Store; Ireland – via HPRA Pharmacovigilance at www.hpra.ie. Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK); 1 800 749 749 (Ireland).

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company.

Adverse events should be reported. Reporting forms and information can be found at: UKwww.mhra.gov/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App Store; Ireland – via HPRA Pharmacovigilance at www.hpra.ie. Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK); 1 800 749 749 (Ireland).

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company.